HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $43,415 | +44.7% | 763 | 0.0% | 0.00% | – |
| Q3 2022 | $30,000 | -16.7% | 763 | -6.4% | 0.00% | – |
| Q2 2022 | $36,000 | +16.1% | 815 | +4.6% | 0.00% | – |
| Q1 2022 | $31,000 | 0.0% | 779 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -13.9% | 779 | -11.5% | 0.00% | – |
| Q3 2021 | $36,000 | -18.2% | 880 | -8.5% | 0.00% | – |
| Q2 2021 | $44,000 | +4.8% | 962 | -4.4% | 0.00% | – |
| Q1 2021 | $42,000 | +2.4% | 1,006 | +5.5% | 0.00% | – |
| Q4 2020 | $41,000 | – | 954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |